Zhengjun Lin

机构：Central South University, Second Xiangya Hospital of Central South University · ORCID：0000-0001-6366-964X

发表论文 46 篇 · 总被引 1369 次 · h-index 13

代表论文

• The crosstalk of CD8+ T cells and ferroptosis in cancer (2024 · Frontiers in Immunology · 被引 72)
• Exosomal circRNAs in cancer: Implications for therapy resistance and biomarkers (2023 · Cancer Letters · 被引 54)
• Cancer therapy resistance mediated by cancer-associated fibroblast-derived extracellular vesicles: biological mechanisms to clinical significance and implications (2024 · Molecular Cancer · 被引 46)
• SPP1 could be an immunological and prognostic biomarker: From pan‐cancer comprehensive analysis to osteosarcoma validation (2024 · The FASEB Journal · 被引 19)
• Harnessing ferroptosis for enhanced sarcoma treatment: mechanisms, progress and prospects (2024 · Experimental Hematology and Oncology · 被引 15)
• Leveraging Artificial Intelligence for Neoantigen Prediction (2025 · Cancer Research · 被引 13)